Results Snapshot
Figures in Cr
Consolidate Annual Results
Mar'25
Net Sales
40.24
Other Operating Income
0.00
Total Operating income
40.24
Raw Material Cost
3.96
Purchase of Finished goods
0.00
(Increase) / Decrease In Stocks
0.00
Employee Cost
8.35
Power Cost
0.00
Manufacturing Expenses
0.00
Selling and Distribution Expenses
0.00
Other Expenses
11.39
Total Expenditure (Excl Depreciation)
23.70
Operating Profit (PBDIT) excl Other Income
16.54
Other Income
0.15
Operating Profit (PBDIT)
16.69
Interest
0.65
Exceptional Items
0.00
Gross Profit (PBDT)
16.04
Depreciation
3.29
Profit Before Tax
12.77
Tax
3.27
Provisions and contingencies
0.00
Profit After Tax
9.50
Extraordinary Items
0.00
Prior Period Expenses
0.00
Other Adjustments
0.00
Net Profit
9.50
Share in Profit of Associates
0.00
Minority Interest
-0.09
Other related items
0.00
Consolidated Net Profit
9.41
Equity Capital
11.37
Face Value
2.0
Reserves
14.57
Earnings per share (EPS)
1.66
Diluted Earnings per share
1.85
Operating Profit Margin (Excl OI)
41.1%
Gross Profit Margin
39.86%
PAT Margin
23.61%
Public Share Holdings (%)
0.0%
Pledged Promotor Holding (%)
0.0%
Annual Analysis Highlights
Analysis not available as Data has been published for only 1 period
Compare Annual Results Of Gujarat Kidney With
Figures in Cr
Consolidate Annual Results
Change(INR)
Change(%)
Net Sales
40.24
337.42
-297.18
-88.07%
Other Operating Income
0.00
0.00
0.00
Total Operating income
40.24
337.42
-297.18
-88.07%
Raw Material Cost
3.96
87.38
-83.42
-95.47%
Purchase of Finished goods
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
Employee Cost
8.35
53.78
-45.43
-84.47%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
11.39
122.42
-111.03
-90.70%
Total Expenditure (Excl Depreciation)
23.70
263.58
-239.88
-91.01%
Operating Profit (PBDIT) excl Other Income
16.54
73.84
-57.30
-77.60%
Other Income
0.15
4.99
-4.84
-96.99%
Operating Profit (PBDIT)
16.69
78.83
-62.14
-78.83%
Interest
0.65
11.15
-10.50
-94.17%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
16.04
67.68
-51.64
-76.30%
Depreciation
3.29
13.59
-10.30
-75.79%
Profit Before Tax
12.77
54.08
-41.31
-76.39%
Tax
3.27
12.42
-9.15
-73.67%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
9.50
41.66
-32.16
-77.20%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
9.50
41.66
-32.16
-77.20%
Share in Profit of Associates
0.00
0.04
-0.04
-100.00%
Minority Interest
-0.09
0.00
-0.09
Other related items
0.00
0.00
0.00
Consolidated Net Profit
9.41
41.70
-32.29
-77.43%
Equity Capital
11.37
79.90
-68.53
-85.77%
Face Value
2.00
10.00
0.00
Reserves
14.57
78.28
-63.71
-81.39%
Earnings per share (EPS)
1.66
5.22
-3.56
-68.20%
Diluted Earnings per share
1.85
5.21
-3.36
-64.49%
Operating Profit Margin (Excl OI)
41.10%
21.88%
0.00
19.22%
Gross Profit Margin
39.86%
20.06%
0.00
19.80%
PAT Margin
23.61%
12.35%
0.00
11.26%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Annual - Net Sales
Net Sales 35.17 Cr
in Mar 2025Figures in Cr
Annual - Standalone Net Profit
Standalone Net Profit 9.11 Cr
in Mar 2025Figures in Cr
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 15.45 Cr
in Mar 2025Figures in Cr
Annual - Interest
Interest 0.53 Cr
in Mar 2025Figures in Cr
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 43.93%
in Mar 2025Figures in %






